Your browser is no longer supported. Please, upgrade your browser.
AGEN Agenus Inc. daily Stock Chart
Agenus Inc.
Index- P/E- EPS (ttm)-0.80 Insider Own24.18% Shs Outstand134.27M Perf Week-3.05%
Market Cap384.01M Forward P/E- EPS next Y-1.29 Insider Trans0.00% Shs Float101.81M Perf Month10.00%
Income-87.30M PEG- EPS next Q-0.33 Inst Own33.30% Short Float10.52% Perf Quarter-4.03%
Sales115.00M P/S3.34 EPS this Y-17.50% Inst Trans16.28% Short Ratio9.77 Perf Half Y32.41%
Book/sh-0.90 P/B- EPS next Y-27.70% ROA-54.10% Target Price6.00 Perf Year-17.82%
Cash/sh- P/C- EPS next 5Y- ROE65.60% 52W Range1.54 - 3.88 Perf YTD20.17%
Dividend- P/FCF- EPS past 5Y-5.30% ROI84.50% 52W High-26.29% Beta1.85
Dividend %- Quick Ratio1.70 Sales past 5Y64.60% Gross Margin- 52W Low85.71% ATR0.13
Employees294 Current Ratio1.70 Sales Q/Q4783.30% Oper. Margin-48.50% RSI (14)51.69 Volatility4.66% 4.76%
OptionableYes Debt/Eq- EPS Q/Q123.50% Profit Margin-75.80% Rel Volume0.74 Prev Close2.96
ShortableYes LT Debt/Eq- EarningsMay 09 BMO Payout- Avg Volume1.10M Price2.86
Recom1.30 SMA202.16% SMA502.14% SMA20012.96% Volume806,339 Change-3.38%
Apr-22-19Initiated B. Riley FBR Buy
Oct-28-16Downgrade H.C. Wainwright Buy → Neutral $10 → $5
Oct-27-16Reiterated Maxim Group Buy
Mar-11-16Upgrade Maxim Group Hold → Buy $7
Dec-16-15Initiated Jefferies Buy
Oct-27-15Downgrade Maxim Group Buy → Hold
Jul-27-15Reiterated MLV & Co Buy $9 → $11
Jun-11-15Initiated Oppenheimer Outperform $14
Jan-12-15Reiterated Maxim Group Buy $10 → $11
Jan-09-15Reiterated MLV & Co Buy $6 → $9
Jan-09-15Reiterated Maxim Group Buy $10 → $11
Dec-19-14Reiterated Maxim Group Buy $8 → $10
May-08-14Reiterated Maxim Group Buy $17 → $11
Mar-14-14Reiterated MLV & Co Buy $9 → $11
Oct-08-13Reiterated Maxim Group Buy $19
Jan-05-12Initiated William Blair Outperform
Dec-01-11Initiated Global Hunter Securities Buy $6
May-24-19 10:53AM  Agenus' (AGEN) Pipeline Progression on Track Amid Competition Zacks
May-15-19 12:14PM  Edited Transcript of AGEN earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-10-19 02:54PM  Agenus (AGEN) Q1 Earnings Beat Estimates, Revenues Miss Zacks
07:24AM  Agenus Inc (AGEN) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 09:05AM  Agenus (AGEN) Surpasses Q1 Earnings Estimates Zacks +8.27%
07:57AM  Agenus: 1Q Earnings Snapshot Associated Press
07:30AM  Agenus Reports First Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
06:30AM  Agenus, Inc. to Host Earnings Call ACCESSWIRE
May-03-19 01:38PM  Agenus to Report First Quarter 2019 Financial Results on May 9, 2019 and Host Conference Call and Webcast PR Newswire
Apr-23-19 07:41AM  Imagine Owning Agenus (NASDAQ:AGEN) And Wondering If The 41% Share Price Slide Is Justified Simply Wall St.
Apr-13-19 09:30AM  Why Is Agenus (AGEN) Down 13% Since Last Earnings Report? Zacks
Apr-08-19 05:25PM  Gilead Files sNDA for Label Expansion of HIV Therapy Descovy Zacks
Apr-02-19 08:30AM  Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody PR Newswire
Mar-21-19 09:00AM  Agenus Announces Clinical Appointments PR Newswire
Mar-20-19 09:15AM  3 Top Growth Stocks to Buy Right Now Motley Fool
Mar-18-19 04:07PM  Edited Transcript of AGEN earnings conference call or presentation 14-Mar-19 12:30pm GMT Thomson Reuters StreetEvents
Mar-14-19 11:13AM  Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up Zacks
10:55AM  Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript Motley Fool
09:30AM  Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates Zacks
08:35AM  Agenus: 4Q Earnings Snapshot Associated Press
08:00AM  Agenus Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update PR Newswire
Mar-13-19 08:30AM  Agenus Milestone Triggers $7.5M Payment from Gilead PR Newswire
Mar-08-19 03:46PM  Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy Zacks -5.65%
Mar-07-19 01:50PM  Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy Zacks +6.79%
Mar-03-19 07:09PM  The 3 Oldest Members of Biotech's Billion-Burned Club Motley Fool
Feb-20-19 08:30AM  Analysis: Positioning to Benefit within Micron Technology, Caterpillar, Agenus, Fossil Group, Marathon Petroleum, and Geo Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -5.68%
Feb-19-19 08:30AM  Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare PR Newswire -12.19%
Feb-15-19 11:41AM  Agenus to Host Call to Launch First Asset-Backed Digital-Security Offering in Healthcare on February 19, 2019 PR Newswire
Feb-08-19 10:25AM  Why Agenus Inc. Stock Took Flight in January Motley Fool
Feb-05-19 08:43AM  Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat Zacks
Jan-31-19 07:18PM  Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales? Zacks
Jan-29-19 08:00AM  Atomic Capital Kicks off Investor Forum Announcing Digital Offering for NASDAQ-Traded Biotech Group, Agenus Inc. PR Newswire
08:00AM  Agenus to Launch the First Asset-Backed Digital Security Offering in Healthcare PR Newswire
Jan-24-19 08:30AM  Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead PR Newswire
Jan-09-19 07:30AM  Research Report Identifies Conagra Brands, W.R. Grace, International Flavors & Fragrances, Spirit Airlines, Sunstone Hotel Investors, and Agenus with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-08-19 08:38AM  Agenus (AGEN) Surges: Stock Moves 9.4% Higher Zacks
Jan-07-19 12:17PM  Why Agenus Stock Is Spiking Today Motley Fool +9.43%
Jan-06-19 10:00AM  All the Pre-JPM News Healthcare Investors Need to Know Motley Fool
Jan-04-19 08:31AM  Are Options Traders Betting on a Big Move in Agenus (AGEN) Stock? Zacks +6.07%
Jan-03-19 04:31PM  Why Celgene, Agenus, and Incyte Jumped Today Motley Fool +11.55%
04:22PM  Here's Why Agenus Shares Rose as Much as 13.5% Today Motley Fool
11:30AM  Agenus Awarded Grant to Enable QS-21 Innovations PR Newswire
Dec-26-18 10:32AM  3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool +12.61%
09:34AM  Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal Zacks
Dec-23-18 09:03AM  2 Beaten-Down Biotech Stocks That Look Like Bargains Now Motley Fool
Dec-21-18 09:19AM  Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead Zacks -8.87%
08:00AM  Major Biotech Deals Making Sector Red Hot ACCESSWIRE
Dec-20-18 12:48PM  Why Agenus Stock Is Soaring Today Motley Fool +23.38%
09:30AM  4 Biotech Stocks Making Moves on Thursday December 20, 2018 ACCESSWIRE
08:28AM  Agenus stock shoots up 60% after announcing drug development deal with Gilead MarketWatch
07:48AM  Gilead, Agenus sign deal to develop immuno-oncology therapies Reuters
07:30AM  Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies PR Newswire
07:30AM  Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies Business Wire
Dec-17-18 07:00AM  Today's Research Reports on Trending Tickers: Amarin Corporation and Agenus ACCESSWIRE -8.68%
Dec-06-18 09:30AM  Why Is Agenus (AGEN) Up 11.6% Since Last Earnings Report? Zacks
Dec-05-18 10:18PM  Here's Why Agenus Stock Popped 51.6% in November Motley Fool
Dec-04-18 12:00PM  Orchestra BioMed Appoints C. Evan Ballantyne as Chief Financial Officer GlobeNewswire -6.85%
Nov-19-18 05:00AM  Edited Transcript of AGEN earnings conference call or presentation 6-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-13-18 04:05PM  Agenus Elects New Board Member Dr. Allison Jeynes-Ellis and Appoints Chief Operating Officer Dr. Jennifer Buell PR Newswire
11:30AM  Agenus to Present at the 2018 Jefferies London Healthcare Conference PR Newswire
Nov-09-18 07:55AM  Report: Developing Opportunities within Agenus, Kirkland's, Preferred Apartment Communities, Gulfport Energy, ProAssurance, and US Ecology Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-08-18 04:28PM  Agenus (AGEN) Q3 Loss Wider Than Expected, Pipeline in Focus Zacks
Nov-06-18 05:42PM  Agenus to Present Data on Neoantigen Vaccines and anti-CD137 Antibody at SITC 2018 PR Newswire
09:00AM  Agenus (AGEN) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:54AM  Agenus: 3Q Earnings Snapshot Associated Press
07:30AM  Agenus Reports Third Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
Oct-31-18 09:23AM  Agenus to Report Third Quarter 2018 Financial Results on November 6, 2018 and Host Conference Call and Webcast PR Newswire
Oct-30-18 10:33AM  Will Agenus (AGEN) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-20-18 07:30AM  Agenus Presents Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018 PR Newswire
Oct-09-18 09:00AM  Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018 PR Newswire
Oct-08-18 08:25AM  Recent Analysis Shows Ryman Hospitality Properties, PennantPark Investment, PS Business Parks, Agenus, Belden, and Robert Half International Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-05-18 08:48AM  Celyad (CYAD) Jumps: Stock Rises 6.8% Zacks
Sep-28-18 08:38AM  Agenus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY PR Newswire
Sep-21-18 07:00AM  Agenus Closes $15 Million Partial Royalty Monetization With XOMA PR Newswire
Sep-19-18 09:27AM  How Does Investing In Agenus Inc (NASDAQ:AGEN) Impact Your Portfolio? Simply Wall St.
Sep-18-18 06:18PM  Agenus Receives Milestone Payment of $5 Million from Incyte Zacks
Sep-17-18 09:00AM  Agenus Receives Milestone Payment from Incyte PR Newswire -7.11%
Sep-14-18 08:57AM  Implied Volatility Surging for Agenus (AGEN) Stock Options Zacks
Sep-07-18 07:32AM  Why Agenus' Stock Perked Up in August Motley Fool
Sep-05-18 07:34PM  AgenTus Therapeutics to Present on the Anti-tumor Activities of Two Proprietary T Cell Receptors (TCRs) at CAR-TCR Summit in Boston, MA PR Newswire
Sep-04-18 09:57AM  Agenus to Present at The Annual B. Riley FBR Healthcare Conference in New York City PR Newswire
Aug-31-18 04:30AM  Agenus (AGEN) Continue to Surge Higher? Zacks +5.24%
Aug-27-18 09:55AM  Edited Transcript of AGEN earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-23-18 10:00AM  Is Agenus Inc. Stock a Buy? Motley Fool
Aug-17-18 07:39AM featured highlights include: Dollar Tree, Agenus, Huntsman, ArcelorMittal and International Paper Zacks
Aug-16-18 08:42AM  Step Beyond Bargain Hunting & Tap Rising P/E With 5 Stocks Zacks
Aug-15-18 01:22PM  Agenus Receives Second Milestone Payment from Merck PR Newswire -5.59%
09:56AM  Agenus (AGEN) Delivering Well on Its Pipeline Candidates Zacks
Aug-10-18 09:32AM  Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat Zacks
Aug-09-18 10:55AM  Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates Zacks
09:52AM  Agenus: 2Q Earnings Snapshot Associated Press
09:42AM  Agenus (AGEN) Reports Narrower than Expected Loss in Q2 Zacks
08:00AM  Agenus Reports Second Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
06:30AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 02:00PM  Agenus to Report Second Quarter 2018 Financial Results on August 9, 2018 and Host Conference Call and Webcast PR Newswire
Jul-30-18 03:55PM  Will Agenus (AGEN) Disappoint Investors This Earnings Season? Zacks +5.08%
Jul-27-18 07:45AM  New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jul-21-18 08:25AM  Should Biotech Investors Fear Dilution? Motley Fool
Jul-17-18 08:37AM  Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4 Benzinga
Jul-16-18 08:37AM  Agenus Appoints Regulatory and Clinical Heads PR Newswire -5.02%
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, LAG-3, and others. In addition, the company develops vaccine programs, including Prophage vaccine candidate; AutoSynVax, a synthetic neoantigen; and PhosPhoSynVax, a vaccine candidate designed to induce immunity against a class of tumor specific neoepitopes. Further, it develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. Additionally, the company engages in the development of CTLA-4 and PD-1 antagonists; and anti-CTLA-4, CD137, and TIGIT antibodies, as well as various multi-specific antibodies that are under various stages of development. Agenus Inc. has collaboration agreements with Incyte Corporation, Merck Sharpe & Dohme, and Recepta Biopharma SA.; and collaboration with Gilead Sciences, Inc. to develop immuno-oncology therapies. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.